Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ1 receptor antagonists: Synthesis, receptor affinity, selectivity and antiallodynic activity

European Journal of Medicinal Chemistry
2019.0

Abstract

The class of tetrahydro-1H-3-benzazepines was systematically modified in 1-, 3- and 7-position. In particular, a F-atom was introduced in β- or γ-position of the 4-phenylbutyl side chain in 3-position. Ligands with the F-atom in γ-position possess higher GluN2B affinity than analogs bearing the F-atom in β-position. This effect was attributed to the reduced basicity of β-fluoro amines. 3-Benzazepines with a benzylic OH moiety show moderate GluN2B affinity, but considerable selectivity over the σ<sub>2</sub> receptor. However, removal of the benzylic OH moiety led to increased GluN2B affinity, but reduced GluN2B/σ<sub>2</sub> selectivity. With respect to GluN2B affinity the phenol 17b with a γ-fluorophenylbutyl moiety in 3-position represents the most interesting fluorinated ligand (K<sub>i</sub>(GluN2B) = 16 nM). Most of the synthesized ligands reveal either similar GluN2B and σ<sub>1</sub> affinity or higher σ<sub>1</sub> affinity than GluN2B affinity. The methyl ether 16b shows high σ<sub>1</sub> affinity (K<sub>i</sub>(σ<sub>1</sub>) = 6.6 nM) and high selectivity over a broad panel of receptors and transporters. The high antiallodynic activity in the mouse capsaicin assay proved the σ<sub>1</sub> antagonistic activity of 16b.

Knowledge Graph

Similar Paper

Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ1 receptor antagonists: Synthesis, receptor affinity, selectivity and antiallodynic activity
European Journal of Medicinal Chemistry 2019.0
Deconstruction – reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors
European Journal of Medicinal Chemistry 2017.0
2-Methyltetrahydro-3-benzazepin-1-ols – The missing link in SAR of GluN2B selective NMDA receptor antagonists
Bioorganic &amp; Medicinal Chemistry 2018.0
Do GluN2B subunit containing NMDA receptors tolerate a fluorine atom in the phenylalkyl side chain?
MedChemComm 2017.0
Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety
Journal of Medicinal Chemistry 2018.0
Enantiomerically Pure 1,3-Dioxanes as Highly Selective NMDA and σ<sub>1</sub>Receptor Ligands
Journal of Medicinal Chemistry 2012.0
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands
Bioorganic &amp; Medicinal Chemistry 2014.0
New combination of pharmacophoric elements of potent σ1 ligands: Design, synthesis and σ receptor affinity of aminoethyl substituted tetrahydrobenzothiophenes
European Journal of Medicinal Chemistry 2013.0
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds
European Journal of Medicinal Chemistry 2020.0
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site☆
European Journal of Medicinal Chemistry 2009.0